Myla Lai-Goldman
North America, Vermont, United States, South Burlington
Description
Myla Lai-Goldman is a Co-Founder and Chair at GeneCentric Therapeutics and a Venture Partner at Hatteras Venture Partners. Myla was an Execu...
Investor Profile
Myla Lai-Goldman has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Artificial Intelligence (AI), Health Care, Machine Learning.
Stage Focus
- Seed (100%)
Country Focus
- United States (100%)
Industry Focus
- Artificial Intelligence (Ai)
- Health Care
- Machine Learning
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
